Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment - Concepedia

Concepedia

Publication | Closed Access

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

217

Citations

22

References

2009

Year

Kimberly Y. Smith, Parul Patel, Derek M. Fine, Nicholaos Bellos, Louis Sloan, Philip Lackey, Princy Kumar, Denise Sutherland‐Phillips, Cindy Vavro, Linda Yau,

Abstract

Both ABC/3TC and TDF/FTC provided comparable antiviral efficacy, safety, and tolerability when each was combined with lopinavir/ritonavir in treatment-naive patients.

References

	Year	Citations

Page 1